Pulse Biosciences Files 8-K with Exhibits
Ticker: PLSE · Form: 8-K · Filed: Apr 16, 2026 · CIK: 0001625101
| Field | Detail |
|---|---|
| Company | Pulse Biosciences, Inc. (PLSE) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, exhibits
TL;DR
Pulse Biosciences dropped an 8-K with exhibits on 4/16/26. Check it for updates.
AI Summary
On April 16, 2026, Pulse Biosciences, Inc. filed an 8-K report detailing its financial statements and exhibits. The filing includes various graphic files, likely presentation slides, and XBRL data, indicating a disclosure of information to the public. No specific financial figures or significant events were detailed in the provided text.
Why It Matters
This filing indicates Pulse Biosciences is providing updated information or disclosures to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, with no immediate indication of significant negative or positive events.
Key Players & Entities
- PULSE BIOSCIENCES, INC. (company) — Filer
- 0001625101 (company) — CIK
- 2026-04-16 (date) — Filing Date
FAQ
What specific financial statements are included in this 8-K filing?
The filing lists 'FORM 8-K' and 'EXTRACTED XBRL INSTANCE DOCUMENT' as included documents, but the specific content of the financial statements is not detailed in the provided text.
What is the purpose of the numerous 'slide' graphic files attached to the filing?
The 'slide' graphic files (slide01.jpg through slide18.jpg) are likely presentation slides intended to accompany the disclosure, possibly for investor relations or public announcement purposes.
When was this 8-K filing accepted by the SEC?
The filing was accepted on 2026-04-16 at 09:00:50.
What are the mailing and business addresses for Pulse Biosciences, Inc.?
The mailing and business addresses for Pulse Biosciences, Inc. are both listed as 3957 POINT EDEN WAY, HAYWARD CA 94545.
What does the 'Regulation FD Disclosure' item (Item 7.01) typically entail?
Regulation FD (Fair Disclosure) requires that when a public company discloses material non-public information to certain persons, it must make public disclosure of that information.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2026 regarding PULSE BIOSCIENCES, INC. (PLSE).